Regeneron Pharmaceuticals REGN spent $320K on lobbying in Q4 2022 · Health Issues, Medicare and 1 more issue

Trade details

Type: Lobbying report
Amount: $320,000
Quarter: Q4 2022
Stock: Regeneron Pharmaceuticals REGN
Client: Regeneron Pharmaceuticals
Reported: 23/01/20

$440K on lobbying in 2022

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals
LobbyingRegeneron Pharmaceuticals
Lobbying
Regeneron Pharmaceuticals
REGN
$50K
$50K
Reported 08/03
for Q2
Regeneron Pharmaceuticals
LobbyingRegeneron Pharmaceuticals
Lobbying
Regeneron Pharmaceuticals
REGN
$630K
$630K
Reported 07/20
for Q2
Regeneron Pharmaceuticals
LobbyingRegeneron Pharmaceuticals
Lobbying
Regeneron Pharmaceuticals
REGN
$50K
$50K
Reported 07/20
for Q2
Regeneron Pharmaceuticals
LobbyingRegeneron Pharmaceuticals
Lobbying
Regeneron Pharmaceuticals
REGN
$90K
$90K
Reported 07/20
for Q2
Regeneron Pharmaceuticals
LobbyingRegeneron Pharmaceuticals
Lobbying
Regeneron Pharmaceuticals
REGN
$90K
$90K
Reported 07/15
for Q2

Regeneron Pharmaceuticals REGN spent $320K on lobbying in Q4 2022 · Health Issues, Medicare and 1 more issue | Whalegun